RxDoctor Payments Data

Alexander Anderson, MD

Urology · Columbia, MONPI 1902326622

Payments from drug & device makers

$6,940in general payments, 2019–2025

Across 82 payments — averaging $84.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Axonics, Inc.$438
  • Medical Device Business Services, Inc.$305
  • Johnson & Johnson$162
  • Astellas Pharma US Inc$111
  • Neotract Inc.$103
  • plus $355 from 14 others

What the payments were for

  • Travel & lodging$3,73854%
  • Food & beverage$2,79740%
  • Education$4046%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,940 in reported general payments places this provider in the 65th percentile of 250 urology providers in Missouri.

See all urology providers in Missouri

Medicare billing

Part B allowed, 2024
$210,469
Medicare patients
463
Services billed
4,509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron208$133,429
GemtesaVibegron187$109,421
Tamsulosin Hcl571$6,101
Trospium Chloride86$5,097
Solifenacin Succinate123$4,966
Methenamine Hippurate85$4,763
Finasteride567$4,662
Alfuzosin Hcl ErAlfuzosin Hcl298$3,327
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst83$3,276
Estradiol58$3,120
Potassium Citrate ErPotassium Citrate58$3,012
Bethanechol Chloride49$2,652
Testosterone Cypionate44$2,219
Fosfomycin Tromethamine14$1,801
Cabergoline21$1,215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$111$133,429208 claims
Sumitomo Pharma America, Inc.Gemtesa$13$109,421187 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 250 urology providers in Missouri.

Other urology in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →